The Netherlands has everything it takes to become the medicine hub in Europe. The question is: how can we realize this ambition of the Dutch pharmaceutical sector together with governments, companies, and scientists? This is stated in the report ‘Boston on the North Sea, a new publication of Vereniging Innovative Geneesmiddelen (VIG).

The Netherlands has a vibrant biopharmaceutical ecosystem of companies, knowledge institutions, universities, and hospitals. Pivot Parks is mentioned as one of the hotspots for companies and leading in fast growth. Want to know more about this report? Download the publication ‘Boston aan de Noordzee’ .

Read the press release of Veneriniging Innovatieve Geneesmiddelen here.